Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Losec 20mg gastro-resistant capsules
0103050P0BBAAAA
|
Losec | Omeprazole | Gastro-Intestinal System | 10,891 |
|
Losec MUPS 20mg gastro-resistant tablets
0103050P0BBAEAN
|
Losec | Omeprazole | Gastro-Intestinal System | 7,020 |
|
Losec MUPS 10mg gastro-resistant tablets
0103050P0BBADAM
|
Losec | Omeprazole | Gastro-Intestinal System | 3,946 |
|
Losec 10mg gastro-resistant capsules
0103050P0BBACAF
|
Losec | Omeprazole | Gastro-Intestinal System | 1,343 |
|
Losec 40mg gastro-resistant capsules
0103050P0BBABAE
|
Losec | Omeprazole | Gastro-Intestinal System | 784 |
|
Losec MUPS 40mg gastro-resistant tablets
0103050P0BBAFAP
|
Losec | Omeprazole | Gastro-Intestinal System | 742 |
|
Losec I.V. 40mg inj vials
0103050P0BBAHBG
|
Losec | Omeprazole | Gastro-Intestinal System | No data available |
|
Losec Infusion 40mg powder for solution for infusion vials
0103050P0BBAGAV
|
Losec | Omeprazole | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.